cGMP Lab, PPD Inc, 8551 Research Way, Suite 90, Middleton, WI 53562, United States.
J Pharm Biomed Anal. 2011 Nov 1;56(3):513-20. doi: 10.1016/j.jpba.2011.06.010. Epub 2011 Jun 22.
Differential deglycosylation was introduced as an effective technique to characterize glycosylation in glycoprotein containing both N-linked and O-linked glycans at both protein and peptide levels. Human IgA1 was used as a model glycoprotein to demonstrate this technique. The glycans attached to Human IgA1 were removed from their attachment sites by an array of enzymes. After reduction by DTT, the resulting deglycoproteins were analyzed by UPLC-ESI TOF MS to estimate the numbers of N-glycan and O-glycan sites through differential masses. The deglycoproteins and unmodified glycoprotein were further digested to deglycopeptide through trypsin digestion. The glycopeptides and deglycopeptides were identified by UPLC-ESI TOF MS. Two N-glycan and four O-glycan sites were identified and confirmed at peptide levels. These results matched those from deglycoproteins. The N-glycosylation site and N-glycan sequence confirmation were also demonstrated in this study.
差异糖基化被引入作为一种有效的技术来表征糖蛋白中的糖基化,包括在蛋白质和肽水平上的 N 连接和 O 连接聚糖。人 IgA1 被用作模型糖蛋白来演示该技术。通过一系列酶从人 IgA1 的附着位点上去除附着的聚糖。用 DTT 还原后,通过 UPLC-ESI TOF MS 分析得到的去糖蛋白,通过差异质量估计 N-聚糖和 O-聚糖位点的数量。去糖蛋白和未修饰的糖蛋白进一步通过胰蛋白酶消化转化为去糖肽。通过 UPLC-ESI TOF MS 鉴定糖肽和去糖肽。在肽水平上鉴定和确认了两个 N-聚糖和四个 O-聚糖位点。这些结果与从去糖蛋白中得到的结果相匹配。本研究还证明了 N-糖基化位点和 N-聚糖序列的确认。